Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05144477 · ClinicalTrials.gov registry record · NA
Family-Authored ICU Diaries to Reduce Fear in Patients Experiencing a Cardiac Arrest (FAID Fear)
A NA study of Cardiac Arrest and Post Traumatic Stress Syndrome, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT05144477: Completed NA study of Cardiac Arrest and Post Traumatic Stress Syndrome, sponsored by Columbia University.
NCT05144477 is a NA study of Cardiac Arrest and Post Traumatic Stress Syndrome that has completed, run by Columbia University. The registered enrollment target is 16 participants, below the 1,479-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05144477, a NA study of Cardiac Arrest and Post Traumatic Stress Syndrome, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The present study will: Aim 1: Enroll 15 family members of CA patients to (a) pilot recruitment procedures, (b) estimate retention, and (c) assess acceptability of study procedures. Family members will be randomized to either complete an ICU diary or to a control condition, and will complete surveys in the ICU, at patient discharge, and 30 days post-discharge. Aim 2: Obtain an estimate of the association of intervention v. control with (i) family member fear (operationalized as cardiac anxiety about the patients' cardiac condition) at hospital discharge and (ii) family member PTSS 30 days post-discharge. Exploratory Aims: Obtain an estimate of the association of intervention v. control with family member aversive cognitions towards exercise at hospital discharge.
Primary Outcome
This is to assess feasibility of recruitment. Potential family member participants whom the study team approaches and agree/consent to take part in the study will be tallied. Specifically, we divided the number of family member participants who enrolled in the study by the number of potential participants referred to the study (enrolled/referred).
Conditions Studied
Interventions
- BEHAVIORAL FAID Fear Intervention
Study Locations (1)
New York
- CUIMC - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-11-29 |
| Est. Completion | 2022-11-30 |
| Phase | NA |
What the finished NCT05144477 record still lists
NCT05144477 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,479-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Cardiac Arrest appearing as the primary indexed condition, and to 1 intervention - of which FAID Fear Intervention is the first listed.
NCT05144477 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05144477 about?
NCT05144477 is a clinical study titled "Family-Authored ICU Diaries to Reduce Fear in Patients Experiencing a Cardiac Arrest (FAID Fear)". The present study will: Aim 1: Enroll 15 family members of CA patients to (a) pilot recruitment procedures, (b) estimate retention, and (c) assess acceptability of study procedures. Family members will be randomized to either complete an ICU diary or to a control condition, and will complete surve...
What is the current status of trial NCT05144477?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2021-11-29. Estimated completion is 2022-11-30.
What conditions does trial NCT05144477 study?
This clinical trial studies the following conditions: Cardiac Arrest, Post Traumatic Stress Syndrome.
What interventions are being tested in trial NCT05144477?
The interventions under investigation include: FAID Fear Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05144477?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05144477 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrest
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05144477's enrollment target sits among peer trials
16 27th of 31 higher than 4 of 31 other Cardiac Arrest trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Arrest trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning
ACTIVE NOT RECRUITING · NA
-
NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest (ARISE)
COMPLETED · NA
-
SmartCPR Trial: An Analysis of a Waveform-Based Automated External Defibrillation (AED) Algorithm on Survival From Out-of-Hospital Ventricular Fibrillation
COMPLETED · NA
-
Open Pilot Trial of a Mind-body Program for Cardiac Arrest Survivors and Their Caregivers
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI